You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026
Filter Results
Select search scope: search across all journals or within the current journal
Search this journal
Enter search terms…
/
You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026
Select search scope: search across all journals or within the current journal
Drug Target Insights is an international, peer-reviewed, open access journal, covering current developments in all areas of the field of clinical therapeutics and focusing on molecular drug targets which include disease-specific proteins, receptors, enzymes, and genes. The journal seeks to elucidate the impact of new therapeutic agents on patient acceptability, preference, satisfaction and quality of life. The journal welcomes unsolicited article proposals. All articles are listed on PubMed and are freely available via PubMed Central.
This journal is a member of the Committee on Publication Ethics (COPE).
Please visit the journal’s homepage for more information, to access full text content, and/or to submit a manuscript.
Abstracting and Indexing
Article Processing Charges (APCs)*
There is no charge for submitting a paper to Drug Target Insights. Upon acceptance of your manuscript, you will be charged a one-time article processing charge (APC) of 1,848 USD. This fee covers the cost of publication and ensures that your article will be freely available.
Benefits of Publishing
The journal offers significant benefits to authors including:
* The article processing charge (APC) is payable when the manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Tax-exempt status can be indicated by providing appropriate registration numbers when payment is requested. Please see further details here.